Prevalence and Risk Factors for Pain and Related Adverse Reactions Among Breast Cancer Survivors on Aromatase Inhibitors

Peking University People's Hospital1,200 enrolled

Overview

We obtained the occurrence of pain sensation, pain mood, sleep, etc. during endocrine therapy in breast cancer patients through telephone follow-up, and analyzed risk factors through artificial intelligence

Study Type

OBSERVATIONAL

Enrollment

1,200

Conditions

Breast Cancer Aromatase Inhibitors Endocrine Therapy Pain Anxiety Depression Sleep

Interventions

No interventionOTHER

No intervention

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: \- Breast cancer survivors on aromatase inhibitors Exclusion Criteria: * Advanced breast cancer

Locations (1)

Peking University People'S Hospital

Beijing, China

RECRUITING

Outcomes

Primary Outcomes

Prevalence and risk factors for pain and related adverse reactions among breast cancer survivors on aromatase inhibitors

Time frame: 2022-10 ---2023-03

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.